News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
403,462 Results
Type
Article (30465)
Company Profile (351)
Press Release (372638)
Multimedia
Podcasts (115)
Webinars (12)
Section
Business (105201)
Career Advice (245)
Deals (17496)
Drug Delivery (76)
Drug Development (65878)
Employer Resources (37)
FDA (8613)
Job Trends (7614)
News (193449)
Policy (14919)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (4)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (4)
Academia (1538)
Academic (1)
Accelerated approval (40)
ADA (34)
Adcomms (27)
Allergies (118)
Alliances (29331)
ALS (178)
Alzheimer's disease (1295)
Antibody-drug conjugate (ADC) (557)
Approvals (8998)
Artificial intelligence (523)
ASCO (340)
Autoimmune disease (311)
Automation (24)
Bankruptcy (150)
Best Places to Work (6617)
BIO (58)
BIOSECURE Act (8)
Biosimilars (170)
Biotechnology (263)
Bladder cancer (213)
Brain cancer (82)
Breast cancer (854)
Cancer (6634)
Cardiovascular disease (330)
Career advice (230)
Career pathing (13)
CAR-T (362)
CDC (16)
Celiac Disease (2)
Cell therapy (909)
Cervical cancer (58)
Clinical research (58093)
Collaboration (1822)
Commercialization (1)
Company closure (6)
Compensation (1015)
Complete response letters (75)
COVID-19 (1368)
CRISPR (116)
C-suite (911)
Cystic fibrosis (123)
Data (7258)
Decentralized trials (1)
Denatured (24)
Depression (121)
Dermatology (71)
Diabetes (385)
Diagnostics (4109)
Digital health (29)
Diversity (9)
Diversity, equity & inclusion (12)
Drug discovery (317)
Drug pricing (89)
Drug shortages (6)
Duchenne muscular dystrophy (283)
Earnings (42545)
Editorial (38)
Employer branding (6)
Employer resources (37)
Events (71940)
Executive appointments (795)
FDA (11405)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (19)
Frontotemporal dementia (31)
Funding (1471)
Gene editing (239)
Generative AI (42)
Gene therapy (660)
GLP-1 (675)
Government (1896)
Grass and pollen (3)
Guidances (221)
Healthcare (10215)
Hematology (189)
HIV (45)
Huntington's disease (56)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (91)
Immunology and inflammation (281)
Immuno-oncology (111)
Indications (175)
Infectious disease (1567)
Inflammatory bowel disease (200)
Inflation Reduction Act (14)
Influenza (69)
Intellectual property (242)
Interviews (28)
IPO (9448)
IRA (28)
Job creations (1318)
Job search strategy (197)
JPM (50)
Kidney cancer (22)
Labor market (39)
Layoffs (367)
Leadership (15)
Legal (2414)
Liver cancer (110)
Longevity (27)
Lung cancer (883)
Lymphoma (465)
Machine learning (51)
Management (9)
Manufacturing (667)
Marketing (2)
MASH (183)
Medical affairs (1)
Medical device (4003)
Medtech (4043)
Mergers & acquisitions (8901)
Metabolic disorders (1088)
mRNA (206)
Multiple sclerosis (142)
NASH (15)
Neurodegenerative disease (362)
Neuropsychiatric disorders (92)
Neuroscience (2577)
Neurotech (1)
NextGen: Class of 2026 (2993)
Non-profit (2132)
Now hiring (48)
Obesity (494)
Opinion (186)
Ovarian cancer (246)
Pain (162)
Pancreatic cancer (370)
Parkinson's disease (323)
Partnered (18)
Patents (476)
Patient recruitment (625)
Peanut (51)
People (34392)
Pharmaceutical (52)
Pharmacy benefit managers (12)
Phase 1 (19775)
Phase 2 (26260)
Phase 3 (17949)
Pipeline (7427)
Policy (162)
Postmarket research (1549)
Preclinical (8393)
Press Release (36)
Prostate cancer (353)
Psychedelics (62)
Radiopharmaceuticals (356)
Rare diseases (968)
Real estate (2177)
Recruiting (14)
Regulatory (14641)
Reports (21)
Research institute (1765)
Resumes & cover letters (25)
Rett syndrome (38)
RNA editing (30)
RSV (38)
Schizophrenia (152)
Series A (270)
Series B (188)
Service/supplier (1)
Sickle cell disease (103)
Special edition (21)
Spinal muscular atrophy (127)
Sponsored (20)
Startups (2369)
State (1)
Stomach cancer (21)
Supply chain (56)
Tariffs (31)
The Weekly (89)
Vaccines (567)
Venture capital (103)
Weight loss (277)
Women's health (76)
Worklife (3)
Date
Today (40)
Last 7 days (343)
Last 30 days (1813)
Last 365 days (21978)
2026 (11392)
2025 (22270)
2024 (25289)
2023 (28066)
2022 (34359)
2021 (35764)
2020 (30915)
2019 (23327)
2018 (17041)
2017 (19230)
2016 (17592)
2015 (20563)
2014 (15390)
2013 (11944)
2012 (12215)
2011 (12292)
2010 (11936)
Location
Africa (249)
Alabama (79)
Alaska (3)
Arizona (137)
Arkansas (8)
Asia (25650)
Australia (4575)
California (10658)
Canada (2634)
China (1309)
Colorado (401)
Connecticut (454)
Delaware (369)
Europe (56996)
Florida (1432)
Georgia (281)
Hawaii (3)
Idaho (25)
Illinois (702)
India (64)
Indiana (366)
Iowa (18)
Japan (418)
Kansas (98)
Kentucky (29)
Louisiana (19)
Maine (16)
Maryland (1127)
Massachusetts (7814)
Michigan (145)
Minnesota (383)
Mississippi (3)
Missouri (70)
Montana (22)
Nebraska (11)
Nevada (62)
New Hampshire (57)
New Jersey (2582)
New Mexico (19)
New York (2831)
North Carolina (1161)
North Dakota (8)
Northern California (5541)
Ohio (262)
Oklahoma (11)
Oregon (29)
Pennsylvania (1771)
Puerto Rico (16)
Rhode Island (28)
South America (344)
South Carolina (15)
Southern California (4150)
Tennessee (92)
Texas (1725)
United States (35389)
Utah (185)
Vermont (1)
Virginia (239)
Washington D.C. (49)
Washington State (871)
West Virginia (2)
Wisconsin (109)
403,462 Results for "cancer therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pancreatic cancer
Elicio crashes on midstage pancreatic cancer miss but will advance to Phase 3
Elicio Therapeutics’ investigational cancer immunotherapy failed to meet the primary endpoint of disease-free survival in a Phase 2 trial—a result the company attributed mostly to a disproportionate number of patients with higher residual disease.
June 15, 2026
·
2 min read
·
Heather McKenzie
Pancreatic cancer
Can Revolution’s ‘miracle’ pancreatic cancer drug be topped? Immuneering, Actuate say yes
Last month, Revolution Medicines’ RAS inhibitor doubled survival in a Phase 3 pancreatic cancer trial. On the biotech’s heels are Immuneering, Actuate Therapeutics, Erasca and more, looking to improve on that result with increased tolerability—and more time for patients.
May 18, 2026
·
7 min read
·
Heather McKenzie
Cell therapy
Agenus cancer cocktail records 0% response rate, missing midstage goal
An investigational cocktail was tied to a 0% overall response rate in patients with gastroesophageal cancer, but developers Agenus and MiNK Therapeutics aren’t giving up on the program just yet.
April 20, 2026
·
2 min read
·
Gabrielle Masson
Cancer
Lilly sees quick return on $2.3B Ajax buy as blood cancer drug shows early efficacy
Eli Lilly’s new JAK2 inhibitor—which it obtained from the recent acquisition of Ajax Therapeutics—reduced spleen volume by more than a third in 70% of patients with myelofibrosis.
June 15, 2026
·
2 min read
·
Tristan Manalac
HIV
Merck, Gilead serve ‘sweet and sour’ spread after HIV win, cancer stumble
While Merck and Gilead Sciences reported back-to-back late-stage victories for their weekly HIV pill, the partners also discontinued a Phase 3 program for their cancer combo after disappointing lung cancer survival data.
June 9, 2026
·
2 min read
·
Tristan Manalac
Press Releases
TrialAssure and Cancer Research UK Collaborate to Advance AI-Supported Regulatory Document Authoring
Cancer Research UK’s Centre for Drug Development is using TrialAssure LINK AI to support medical writing in CRUK-sponsored studies
June 18, 2026
·
1 min read
Approvals
Gilead’s TROP-2 Trodelvy, Keytruda combo win first-line FDA nods for breast cancer
Gilead’s Trodelvy can now be used as a monotherapy and in combination with Merck’s Keytruda to treat certain patients with triple-negative breast cancer.
June 25, 2026
·
1 min read
·
Tristan Manalac
Cancer
AACR 2026: Combo therapies by Moderna, Marengo show promise in skin, breast cancer
Cancer cocktails pairing Moderna’s mRNA-4359 with Merck’s Keytruda and Marengo’s invikafusp alfa with Gilead Sciences’ Trodelvy showed promising results, while a complex combination by Agenus and MiNK Therapeutics failed to elicit an overall response.
April 28, 2026
·
5 min read
·
Andrea Park
FDA
FDA’s absent leaders, the millions pharma CEOs make, and pancreatic cancer’s momentum
Fallout from the resignation of FDA Commissioner Marty Makary continues as several other senior regulators are removed from their posts; pharma’s top paid CEOs make up to 358 times more than their employees; Revolution Medicine’s pancreatic cancer results highlight movement in the deadly disease space; more.
May 20, 2026
·
1 min read
·
Jef Akst
Press Releases
Antares Therapeutics Enters Agreement with Novartis to Discover, Develop and Commercialize First-in-Class Cancer Therapies
June 24, 2026
·
2 min read
1 of 40,347
Next
